Allogene Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.00

+0.04 (+2.04%)

As of Jun 21, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 85%

Hold 3 15%

Sell 0 0%

Price Target

Analyst Price Target +1,000.5% upside

Low Target $17.29

Average Target $22.01

High Target $30.07

Current Price $2.00

Current
$2.00

Target
$22.01

$17.29 $22.01 avg $30.07

Scenario Analysis

Bear Case

$17.29

764.5%

Low target

Base Case

$22.01

+1,000.5%

Avg target

Bull Case

$30.07

+1,403.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.46

-55.2% from high

52-Week Low

$0.98

+104.1% from low

Target vs 52W High

$22.01

+393.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%